Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3351 results

Sort By:

Alternating Triamcinolone and Platelet-Rich Plasma Therapy for Oral Submucous Fibrosis

Study ID: NCT07277998
Start Date: 2026-03
End Date: 2026-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Platelet-Rich Plasma (PRP) Injections

Triamcinolone Acetonide

Sponsor

Karachi Medical and Dental College

Source: clinicaltrials.gov

Share:
Add to list

A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy

Study ID: NCT05896371
Start Date: 2028-03
End Date: 2034-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

500

Intervention / Treatment

177Lu-PSMA-I&T - escalating renal absorbed dose

177Lu-PSMA-I&T - recommended phase 2 regime

Sponsor

CHU of Quebec-Universite Laval

Source: clinicaltrials.gov

Share:
Add to list

Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests

Study ID: NCT07106632
Start Date: 2026-01-01
End Date: 2038-06-15
Study Type

Interventional

Study Phase

Phase3

No. of Participants

3380

Intervention / Treatment

test-directed treatment: allocated treatment will depend on the PAM50 score result (centrally assessed) : chemo-endocrine therapy or endocrine therapy alone

In the control arm, the treatment will be as standard of care : chemo-endocrine therapy

Sponsor

UNICANCER

Source: clinicaltrials.gov

Share:
Add to list

A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer

Study ID: NCT07223463
Start Date: 2026-03
End Date: 2030-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

160

Intervention / Treatment

Tailored Program

Feedback Program (Uniform Standard of Care)

Sponsor

Children's Hospital Medical Center, Cincinnati

Source: clinicaltrials.gov

Share:
Add to list

Itraconazole Therapy In Bronchiectasis With Airway Mold

Study ID: NCT07283497
Start Date: 2025-12-15
End Date: 2030-12-31
Study Type

Interventional

Study Phase

Phase4

No. of Participants

30

Intervention / Treatment

Itraconazole 200 mg

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Efficacy and Safety of Tirzepatide (Spartina) in Chronic Kidney Failure

Study ID: NCT07176663
Start Date: 2026-02-01
End Date: 2026-05-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

15

Intervention / Treatment

Tirzepatide

Sponsor

Shahid Beheshti University of Medical Sciences

Source: clinicaltrials.gov

Share:
Add to list

Bone Health in Postmenopausal Women: The Effect of Exercise With or Without Medication for Osteoporosis

Study ID: NCT07267325
Start Date: 2026-01-01
End Date: 2027-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

110

Intervention / Treatment

EXERCISE TRAINING

Antiresorptive medication (routine clinical care)

Sponsor

Loughborough University

Source: clinicaltrials.gov

Share:
Add to list

Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in Adolescents

Study ID: NCT07092813
Start Date: 2026-01
End Date: 2026-07
Study Type

Interventional

Study Phase

Phase1

No. of Participants

12

Intervention / Treatment

sulopenem etzadroxil and probenecid

Sponsor

Iterum Therapeutics, International Limited

Source: clinicaltrials.gov

Share:
Add to list

Dental-Child Interaction Training

Study ID: NCT06138405
Start Date: 2026-01-15
End Date: 2029-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

264

Intervention / Treatment

Immediate intervention Group

Delayed intervention (control) Group

Sponsor

University of Florida

Source: clinicaltrials.gov

Share:
Add to list

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

Study ID: NCT06694454
Start Date: 2025-12-18
End Date: 2034-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

azacytidine

carboplatin

paclitaxel

durvalumab

cisplatin

gemcitabine

pemetrexed

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list